#ASH16: Pfizer offers a thumbs-up on OS data from PhII blood cancer study of glasdegib
Pfizer came up with some solidly positive Phase II data for a new drug that’s designed to throw a monkey wrench into the biology …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
